In head-to-head comparisons across trials, retatrutide consistently produces greater weight reduction than both semaglutide and tirzepatide at equivalent timepoints
If we go back to like type 1 diabetes for instance, right that person's pancreas is just not producing insulin the way that a quote-unquote healthy body would, and so we need to give them insulin to fix a dysfunction
One study found that four percent of Americans are taking GLP-1s, which reflects a 600 percent increase in the last five years
Some describe it as having my spark back. Others simply notice fewer dips in focus or mood
Glucagon-like peptide-1 (GLP-1) receptor agonists are licensed for type 2 diabetes and weight management, not inflammatory conditions
Step four: consider compounded alternatives If brand name medications are not financially viable, compounded versions offer a significantly lower-cost pathway to continued treatment